Navigation Links
Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing
Date:12/6/2011

PHILADELPHIA, Dec. 6, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced a registered direct equity financing of approximately $5.4 million by issuing units, with each unit consisting of one share of its common stock and a warrant to purchase 0.4 of a share of its common stock.  The company has entered into purchase agreements with current investors and other select institutional and strategic investors to buy a total of approximately 2.4 million units at a price of $2.25 per unit. 

The offering is expected to close on or about December 7, 2011, subject to customary closing conditions.  Each warrant will have an exercise price of $3.00 per share, will be exercisable six months after the date of issuance and will expire three years from the date of issuance.  The shares of common stock and warrants are immediately separable and will be issued separately.

The company conducted the financing without the services of a placement agent or underwriter.

The securities described above are being offered by Echo Therapeutics pursuant to a shelf registration statement previously filed with, and declared effective by, the Securities and Exchange Commission (the "SEC").  A prospectus supplement relating to the offering has been filed with the SEC and is available on the SEC's website located at www.sec.gov.  Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be also obtained from Echo Therapeutics, Inc., 8 Penn Center, 1628 JFK Blvd., Suite 300, Philadelphia, Pennsylvania 19103, Attention: Kimberly Burke, General Counsel, e-mail: '/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... and MENLO PARK, Calif. , Aug. ... DMPI), developer of advanced cancer therapeutics , will ... Annual Rodman & Renshaw Global Investment Conference, sponsored by ... take place Tuesday, September 9th at 2:55 p.m. EDT ... New York Palace Hotel in New York ...
(Date:8/27/2014)... 2014  Decision Resources Group finds that physicians ... rheumatology, gastroenterology, endocrinology and nephrology) expect the robustness ... has been assessed in to be the strongest ... prescribe. Other key findings from ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... TAMPA, Fla. , Aug. 27, 2014 ... announced today that it has released a preview of ... helping the pharmaceutical industry avoid drug shortages and maintain ... world-wide. The Plan, a first for ... pharmaceutical and biopharmaceutical industry members and describes how industry ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4
(Date:8/27/2014)... August 27, 2014 Reviewing the prices ... now be easier for the public when using the ... are promoted in all 50 states in the U.S. ... The different insurers that are generating the rates information ... for adults to use the programmed system without charge. ...
(Date:8/27/2014)... 2014 The New York Mobility Club ... free events about “ Sexuality & Intimacy ” for ... straightforward and entertaining discussions are for mature audiences only. ... Concord Avenue, Mamaroneck, NY) and October 7 from 6-8 ... , The New York Mobility Club is a ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s running ... runner, Kathrine Switzer, most noted for her brave running of ... line of women’s running clothes that unites the history of ... Fearless Movement. , “It is such an honor ... “Kathrine is the original Skirt – she stood strong, ...
(Date:8/27/2014)... 27, 2014 Seventy-three members of the ... celebrated the beginning of their careers as healthcare professionals ... 23. Students entering a four-year PharmD program traditionally receive ... welcome them into the profession as colleagues dedicated to ... at the Garrison Theater in Claremont, Calif., KGI President ...
(Date:8/27/2014)... topical agents and light to kill tissue) appears to ... caused by sun damage) at three months after treatment ... , Author: Gayatri Patel, M.D., M.P.H., of ... and colleagues. , Background: AKs are rough, ... with fair complexions who have had lots of sun ...
Breaking Medicine News(10 mins):Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2
... Oct. 18 Medical Decisions Network,(MDN) announces Food ... IV Insulin Dosing Software. The MDN-CGS software is ... the dosage of,intravenous insulin administered to patients with ... sugar the body converts to energy for survival. ...
... Reduce Number Denied by President, a Few in Congress, ... will join the ranks of the uninsured, adding to ... health insurance,according to new data released today by the ... analysis, American Families Face Harsh Reality: 2,000 Children,Join the ...
... 18 Yankee Candle Company,Inc., the country,s #1 ... is,taking action in the fight against breast cancer. ... http://www.newscom.com/cgi-bin/prnh/20071018/NYTH093LOGO-b ) Yankee Candle Company created ... and research. The company is donating $1.00 from ...
... returning U.S. veterans , , THURSDAY, Oct. 18 (HealthDay News) ... when deciding how best to treat post-traumatic stress disorder ... of the data concludes. , The Institute of Medicine ... Affairs, which noted that about 12.6 percent of personnel ...
... Haas (NYSE:,ROH) announced today that it has ... used as a bonding alternative for pressure,sensitive ... like,door panels, interior pillars, instrument panels and ... before seen or thought possible,in an aqueous ...
... 18 Capsugel, the,leading global provider of dosage ... and sealing machines have now been licensed by,eight ... integral part of,the Licaps(R) Drug Delivery System, these ... machines in early stage,development and manufacturing of Phase ...
Cached Medicine News:Health News:FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software 2Health News:Families Face Harsh Reality: 2,000 Children Join the Uninsured Each Day 2Health News:Yankee Candle Company Sheds Some Light In The Fight Against Breast Cancer 2Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 2Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 3Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 4Health News:New Water-Based Acrylic Pressure-Sensitive Adhesive Defeats Heat and Humidity Issue 2Health News:Capsugel's Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies 2
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
... itself to over 2,000 medical clinics nation ... user in mind, ChartingPlus relies heavily on ... features to improve documentation quality and increase ... Our medical content is specific to your ...
Transfer your exams to AltaPoint with our EMR Exam Word Lists. Document systems as normal and annotate exceptions to the systems in the exam. AltaPoint EMR is configured to allow a specialty to cust...
... Clinic Pro Software developed a touchscreen EHR ... spring. While a user can choose to ... practitioner to maintain eye contact while recording ... Clinic Pro EHR also runs on a ...
Medicine Products: